Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GE HealthCare Technologies (GEHC) EBIT Margin (2022 - 2025)

Historic EBIT Margin for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to 14.51%.

  • GE HealthCare Technologies' EBIT Margin fell 5500.0% to 14.51% in Q4 2025 from the same period last year, while for Dec 2025 it was 13.4%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 13.4% for FY2025, which is 500.0% up from last year.
  • GE HealthCare Technologies' EBIT Margin amounted to 14.51% in Q4 2025, which was down 5500.0% from 12.7% recorded in Q3 2025.
  • In the past 5 years, GE HealthCare Technologies' EBIT Margin registered a high of 15.74% during Q4 2022, and its lowest value of 11.61% during Q1 2024.
  • Its 4-year average for EBIT Margin is 13.19%, with a median of 13.11% in 2025.
  • Per our database at Business Quant, GE HealthCare Technologies' EBIT Margin plummeted by -25000bps in 2023 and then soared by 18200bps in 2024.
  • GE HealthCare Technologies' EBIT Margin (Quarter) stood at 15.74% in 2022, then decreased by -16bps to 13.23% in 2023, then rose by 14bps to 15.06% in 2024, then dropped by -4bps to 14.51% in 2025.
  • Its EBIT Margin stands at 14.51% for Q4 2025, versus 12.7% for Q3 2025 and 13.06% for Q2 2025.